Financing ·
OS Therapies Inc terminated its At Market Issuance Sales Agreement with B. Riley Securities, Inc. and JonesTrading…
OSTXOS Therapies Inc
OS Therapies Inc terminated its At Market Issuance Sales Agreement with B. Riley Securities, Inc. and JonesTrading Institutional Services LLC effective July 28, 2026. The agreement allowed for the sale of up to $18 million in common stock; however, only 282,679 shares were sold for approximately $530,162 in gross proceeds before termination. Approximately $17.47 million remained unsold under the facility. No termination fees or payments were due by either party. OS Therapies Inc operates in the biotechnology industry and focuses on developing therapies for rare diseases.